NCT02949778

Quadratus Lumborum Block for Abdominoplasty

Quadratus Lumborum Block for Perioperative Analgesia in Patients Treated With Abdominoplasty: A Randomised Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Vestre Viken Hospital Trust · Academic / Other
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

Double blinded, randomized, controlled, phase IV intervention trial. Both groups will receive a quadratus lumborum Block (QL), using ropivacaine 3.75 mg/mL in the intervention group, and sterile sodium chloride in the control group. The aim of study is to investigate the effect of a QL Block on the perioperative pain during postbariatric abdominoplasty.

Conditions

• Pain, Postoperative
• Abdominoplasty

Interventions

Type	Name	Description
PROCEDURE	QL-block	Bilateral quadratus lumborum block using either ropivacaine 3.75mg/ml or sodium chloride 0.9% is the intervention studied
DRUG	Ropivacaine	Ropivacaine 3.75mg/ml administered in QL-block as active treatment
DRUG	Sodium Chloride	Sodium chloride 9mg/mL administered in QL-Block as placebo

Timeline

• Start date: 2016-11-07
• Primary completion: 2017-06-15
• Completion: 2017-12-13
• First posted: 2016-10-31
• Last updated: 2017-12-19

Locations

1 site across 1 country: Norway